Literature DB >> 9367819

Purification in quantity of the secreted form of WI-1: a major adhesin on Blastomyces dermatitidis yeasts.

R Audet1, T T Brandhorst, B Klein.   

Abstract

WI-1, a 120-kDa adhesin on Blastomyces dermatitidis, binds the yeast to macrophages and is a major target antigen of immune recognition in acquired resistance to the fungus. In past studies, WI-1 has been purified by extracting the protein from the yeast cell wall, which yields microgram quantities for biological assays. We report a strategy for generating and purifying the secreted form of WI-1 in quantity. Yeasts of B. dermatitidis ATCC strain 60636 cultured in HMM medium were found to secrete 10 microg/ml of WI-1 into a supernate relatively free of other medium and yeast components. Using a two-step method of ion exchange and hydrophobic interaction chromatography, we achieved a 7.1-fold purification of WI-1. Purified WI-1 was sequenced at the N-terminus which revealed that the secreted protein exists in two different forms. In functional assays, purified WI-1 also retained its adhesivity for human macrophages, and its antigenicity in binding anti-WI-1 antibodies and stimulating T-cells to proliferate, but it lost some capacity to elicit delayed-type hypersensitivity in mice. These findings advance our understanding of the WI-1 adhesin/antigen and our ability to express and purify WI-1 in quantity and will permit a study of the relationship between three-dimensional structure and activity of the molecule. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9367819     DOI: 10.1006/prep.1997.0783

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  5 in total

1.  Interleukin 12 as an adjuvant to WI-1 adhesin immunization augments delayed-type hypersensitivity, shifts the subclass distribution of immunoglobulin G antibodies, and enhances protective immunity to Blastomyces dermatitidis infection.

Authors:  M Wüthrich; B E Finkel-Jiminez; B S Klein
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

2.  T-Cell epitopes and human leukocyte antigen restriction elements of an immunodominant antigen of Blastomyces dermatitidis.

Authors:  W L Chang; R G Audet; B D Aizenstein; L H Hogan; R I DeMars; B S Klein
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Mutation of the WI-1 gene yields an attenuated blastomyces dermatitidis strain that induces host resistance.

Authors:  M Wüthrich; H I Filutowicz; B S Klein
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

4.  Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis.

Authors:  M Wüthrich; W L Chang; B S Klein
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

5.  Structure and function of a fungal adhesin that binds heparin and mimics thrombospondin-1 by blocking T cell activation and effector function.

Authors:  T Tristan Brandhorst; René Roy; Marcel Wüthrich; Som Nanjappa; Hanna Filutowicz; Kevin Galles; Marco Tonelli; Darrell R McCaslin; Kenneth Satyshur; Bruce Klein
Journal:  PLoS Pathog       Date:  2013-07-11       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.